trofosfamide has been researched along with Metastase in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, S; Chemnitz, JM; Eckert, R; Fix, P; Geissler, M; Gruenwald, V; Hann von Weyhern, C; Hartmann, JT; Hofheinz, R; Horger, M; Kopp, HG; Kunitz, A; Mayer, F; Mueller, L; Neise, M; Piperno-Neumann, S; Wehler, T; Zander, I | 1 |
| Deutschbein, T; Fassnacht, M; Hahner, S; Heidemeier, A; Kroiss, M; Müller, HH; Neu, B; Quinkler, M; Ronchi, CL; Schlötelburg, W | 1 |
| Atzpodien, J; Fluck, M; Morawek, L; Reitz, M | 1 |
| Haber, DA; Maheswaran, S | 1 |
| Aigner, B; Becker, JC; Lingitz, H; Marterer, R; Niederkorn, A; Richtig, E; Ugurel, S | 1 |
| Dörken, B; Kretzschmar, A; Pink, D; Reichardt, P; Thuss-Patience, PC; Tilgner, J | 1 |
| Hartmann, JT; Kanz, L; Kopp, HG | 1 |
| Mauch, C | 1 |
| Albrecht, M; Jepsen, G; Thomsen, K; Trams, G | 1 |
| Blomqvist, C; Elomaa, I; Pajunen, M; Virolainen, M; Wiklund, T | 1 |
| Böhm, P; Bokemeyer, C; Brugger, W; Hartmann, JT; Kanz, L; Kollmannsberger, C; Maurer, F | 1 |
1 review(s) available for trofosfamide and Metastase
| Article | Year |
|---|---|
Circulating tumor cells: a window into cancer biology and metastasis.
Topics: Cell Separation; Cyclophosphamide; Drug Delivery Systems; Humans; Neoplasm Metastasis; Neoplastic Cells, Circulating; Neoplastic Stem Cells | 2010 |
3 trial(s) available for trofosfamide and Metastase
| Article | Year |
|---|---|
Randomised phase II trial of trofosfamide vs. doxorubicin in elderly patients with untreated metastatic soft-tissue sarcoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Sarcoma | 2020 |
Oral trofosfamide: an active drug in the treatment of soft-tissue sarcoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Disease-Free Survival; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Sarcoma | 1995 |
Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Cyclophosphamide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Palliative Care; Sarcoma | 1999 |
7 other study(ies) available for trofosfamide and Metastase
| Article | Year |
|---|---|
Salvage Treatment of Adrenocortical Carcinoma with Trofosfamide.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Retrospective Studies; Salvage Therapy; Treatment Outcome; Tumor Burden; Young Adult | 2016 |
Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Female; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Survival Analysis; Vinblastine; Vinorelbine | 2009 |
Partial response of metastatic mucosal melanoma after palliative chemotherapy with trofosfamide: a case report.
Topics: Adrenal Gland Neoplasms; Aged, 80 and over; Antineoplastic Agents, Alkylating; Cyclophosphamide; Female; Humans; Melanoma; Neoplasm Metastasis; Palliative Care; Paranasal Sinus Neoplasms; Pleural Neoplasms | 2013 |
Oral trofosfamide: an active and well-tolerated maintenance therapy for adult patients with advanced bone and soft tissue sarcomas. Results of a retrospective analysis.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Bone Neoplasms; Cyclophosphamide; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms | 2002 |
Hypersensitivity pneumonitis associated with the use of trofosfamide.
Topics: Administration, Oral; Aged; Alveolitis, Extrinsic Allergic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cystitis; Drug Administration Schedule; Female; Femur; Germany; Humans; Ifosfamide; Nausea; Neoplasm Metastasis; Nerve Sheath Neoplasms; Phosphoramide Mustards; Prednisolone; Pulmonary Fibrosis; Vomiting | 2004 |
[Metronomic chemotherapy. Should we change our thinking in the treatment of advanced tumors?].
Topics: Administration, Oral; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bevacizumab; Breast Neoplasms; Busulfan; Cyclooxygenase 2 Inhibitors; Cyclophosphamide; Drug Therapy, Combination; Female; Forecasting; Humans; Male; Melanoma; Neoplasm Metastasis; Neoplasms; Prospective Studies; Quality of Life; Skin Neoplasms; Time Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2005 |
[Ancillary chemotherapy with trofosfamid, methotrexate and fluoro-uracil in cancer of the breast (author's transl)].
Topics: Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local | 1981 |